Source: Eur Respir J, 54 (3) 1901417; 10.1183/13993003.01417-2019



Rating:

Share or cite this content

Citations should be made in the following way:
Constantine I. Vardavas, Christina N. Kyriakos, Esteve Fernández, Panagiotis Bamidis, Kamran Siddiqi, Niels H. Chavannes, R.M.J.J. van der Kleij, Gary Parker, Cornel Radu-Loghin, Brian Ward, Karim Berkouk. H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases. Eur Respir J, 54 (3) 1901417; 10.1183/13993003.01417-2019

Member's Comments

No comment yet.

Related content which might interest you: Prioritised research agenda for prevention and control of chronic respiratory diseases Source: Eur Respir J 2010; 36: 995-1001 Year: 2010 Mitigation of occupational respiratory diseases: role of regional respiratory societies and policies in clinical practice and education Source: International Congress 2016 – Occupational lung disease worldwide Year: 2016 Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003 The new WHO air quality guidelines: policy and clinical implications for children with respiratory diseases Source: Virtual Congress 2021 – The environment and climate change effects on lung health across the lifecourse Year: 2021 Optimising experimental research in respiratory diseases: an ERS statement Source: Guideline 2018 Year: 2018 Optimising experimental research in respiratory diseases: an ERS statement Source: Eur Respir J, 51 (5) 1702133; 10.1183/13993003.02133-2017 Year: 2018 The economic burden of respiratory diseases: lung cancer and oxygen treatment Source: Eur Respir Monogr 2014; 65: 106-115 Year: 2014 Delivering telemedicine interventions in chronic respiratory disease Source: Breathe 2014; 10: 198-212 Year: 2014 The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective Source: International Congress 2019 – Rare lung diseases Year: 2019 Survey of COPD management among the primary care physicians in Korea – study for the development and dissemination of the COPD guidelines – clinical research center for chronic obstructive airway disease Source: Annual Congress 2008 - COPD epidemiology Year: 2008 Post-genome respiratory epidemiology: a multidisciplinary challenge Source: Eur Respir J 2004; 24: 471-480 Year: 2004 COVID-19: impact on respiratory patients and prevention Source: Virtual Congress 2021 – Clinical year in review Year: 2021 A development study of pulmonary rehabilitation for patients with chronic lung disease in Uganda Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases Source: Eur Respir Monogr 2017; 77: 224-246 Year: 2017 The growing chronic disease burden in Europe: a role for respiratory health professionals? Source: Eur Respir J 2014; 43: 1249-1251 Year: 2014 Economic aspects of enhanced testing strategies for respiratory diseases Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021